FeesSafety
Pluang+

Binance skips monthly Luna Classic token burn for first time, causing community concern.

Market News
03 Nov 2026, 14:20 WIB
Crypto Briefing
View Source
Neutral
Binance skips monthly Luna Classic token burn for first time, causing community concern.

Binance did not perform its usual monthly burn of Luna Classic (LUNC) tokens on November 1, marking the first missed burn since the program began in 2023. The burn involves using trading fees to buy back and destroy LUNC tokens, reducing supply. Binance has not explained the delay, though one community theory suggests they are moving tokens to a more secure wallet. While the missed burn is a small fraction of the total supply and has had little immediate market impact, it raises concerns about Binance's ongoing commitment to the token's supply reduction. The community awaits an official statement or a December burn to clarify the program's future.

Binance's missed November burn of Luna Classic tokens provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 03, 2026 19:03 WIB: out of 50 priced major cryptocurrencies, 12 rose and 37 fell today. Notable movers include MANA (Decentraland) at Rp1.300 with a 1-day change of -2.91% and a typical hold time of 157 days, COTI at Rp179 down 2.84%, and AAVE at Rp2.321.733 down 2.81%, with Pluang order activity showing mostly sell pressure on these assets.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
34 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
34 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
34 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App